[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CY1106180T1 - Σκευασματα διασπορας τα οποια πepιεχουν αναστολεις λιπασης - Google Patents

Σκευασματα διασπορας τα οποια πepιεχουν αναστολεις λιπασης

Info

Publication number
CY1106180T1
CY1106180T1 CY20061101416T CY061101416T CY1106180T1 CY 1106180 T1 CY1106180 T1 CY 1106180T1 CY 20061101416 T CY20061101416 T CY 20061101416T CY 061101416 T CY061101416 T CY 061101416T CY 1106180 T1 CY1106180 T1 CY 1106180T1
Authority
CY
Cyprus
Prior art keywords
inhibitors
dispersions containing
containing lipstick
lipstick
inhibitor
Prior art date
Application number
CY20061101416T
Other languages
English (en)
Inventor
Passchier Christiaan De Smidt
Paul Hadvary
Hans Lengsfeld
Thomas Rades
Hans Steffen
Joseph Tardio
Original Assignee
F. Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8238990&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1106180(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by F. Hoffmann-La Roche Ag filed Critical F. Hoffmann-La Roche Ag
Publication of CY1106180T1 publication Critical patent/CY1106180T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Η παρούσα εφεύρεση σχετίζεται με μία φαρμακευτική σύνθεση η οποία περιλαμβάνει τουλάχιστον έναν αναστολέα λιπασών, κατά προτίμηση έναν αναστολέα γαστρεντερικών και παγκρεατικών λιπασών, π.χ. ορλιστάτη, και τουλάχιστον ένα τασιενεργό και τουλάχιστον έναν παράγοντα διασποράς.
CY20061101416T 1999-09-13 2006-09-29 Σκευασματα διασπορας τα οποια πepιεχουν αναστολεις λιπασης CY1106180T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99118180 1999-09-13
PCT/EP2000/008858 WO2001019340A1 (en) 1999-09-13 2000-09-11 Dispersion formulations containing lipase inhibitors
EP00960643A EP1216025B1 (en) 1999-09-13 2000-09-11 Dispersion formulations containing lipase inhibitors

Publications (1)

Publication Number Publication Date
CY1106180T1 true CY1106180T1 (el) 2011-06-08

Family

ID=8238990

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20061101416T CY1106180T1 (el) 1999-09-13 2006-09-29 Σκευασματα διασπορας τα οποια πepιεχουν αναστολεις λιπασης

Country Status (39)

Country Link
US (3) US20030181512A1 (el)
EP (1) EP1216025B1 (el)
JP (1) JP4217016B2 (el)
KR (1) KR100572434B1 (el)
CN (1) CN1197551C (el)
AR (1) AR025587A1 (el)
AT (1) ATE333866T1 (el)
AU (1) AU769415B2 (el)
BR (2) BRPI0013939B1 (el)
CA (1) CA2383916C (el)
CO (1) CO5180587A1 (el)
CY (1) CY1106180T1 (el)
CZ (1) CZ301901B6 (el)
DE (1) DE60029602T2 (el)
DK (1) DK1216025T3 (el)
EG (1) EG24117A (el)
ES (1) ES2267563T3 (el)
HK (1) HK1049966A1 (el)
HR (1) HRP20020205B1 (el)
HU (1) HU228858B1 (el)
IL (1) IL148494A0 (el)
JO (1) JO2386B1 (el)
MA (1) MA26818A1 (el)
ME (1) MEP90808A (el)
MX (1) MXPA02002034A (el)
MY (1) MY130200A (el)
NO (1) NO331906B1 (el)
NZ (1) NZ517545A (el)
PE (1) PE20010595A1 (el)
PL (1) PL199870B1 (el)
PT (1) PT1216025E (el)
RS (1) RS50422B (el)
RU (1) RU2239428C2 (el)
SI (1) SI1216025T1 (el)
TR (1) TR200200606T2 (el)
TW (1) TWI243060B (el)
UY (1) UY26338A1 (el)
WO (1) WO2001019340A1 (el)
ZA (1) ZA200201518B (el)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL204443B1 (pl) * 2000-07-28 2010-01-29 Hoffmann La Roche Kompozycja farmaceutyczna zawierająca inhibitor lipazy, sposób wytwarzania kompozycji farmaceutycznej, zestaw do leczenia otyłości, zastosowanie kompozycji farmaceutycznej oraz zastosowanie orlistatu i substancji wiążącej kwasy żółciowe
US6730319B2 (en) * 2001-06-06 2004-05-04 Hoffmann-La Roche Inc. Pharmaceutical compositions having depressed melting points
US20030027786A1 (en) 2001-06-06 2003-02-06 Karsten Maeder Lipase inhibiting composition
US8372430B2 (en) * 2002-12-17 2013-02-12 The Procter & Gamble Company Compositions, methods, and kits useful for the alleviation of gastrointestinal effects
FI20045076A (fi) * 2004-03-15 2005-09-16 Bioferme Oy Funktionaalinen elintarvike
WO2006113505A2 (en) * 2005-04-15 2006-10-26 Clarus Therapeutics, Inc. Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same
KR100910000B1 (ko) * 2005-05-13 2009-07-29 씨제이제일제당 (주) 리파아제 저해제 함유 약학 조성물
PT1897558E (pt) * 2005-06-09 2013-11-06 Norgine Bv Preparação sólida de 2-hexadeciloxi-6-metil-4h-3,1- benzoxazin-4-ona
KR100669497B1 (ko) * 2005-08-17 2007-01-16 보람제약주식회사 안정성과 용출률이 뛰어난 약리학적 조성물 및 그 제조방법
WO2007033522A1 (fr) * 2005-09-21 2007-03-29 Shenzhen Tys R & D Co., Ltd. Formulation de gélule contenant de la moxifloxacine et son procédé de préparation
KR101252635B1 (ko) * 2006-04-20 2013-04-10 (주)아모레퍼시픽 리파아제 저해제 및 친유성 오일흡수제를 포함하는 약학조성물 및 이로부터 제조된 경구 투여용 제제
TR200607613A2 (tr) * 2006-12-29 2008-07-21 NOBEL İLAÇ SAN.ve TiC.A.Ş. Lipaz inhibitörü içeren farmasötik formülasyonlar
EP1970051A1 (en) * 2007-03-14 2008-09-17 Merz Pharma GmbH & Co.KGaA Use of an aqueous micro-emulsion for the preparation of a formulation for the treatment of adipose diseases
KR101439470B1 (ko) * 2007-05-22 2014-09-16 한미사이언스 주식회사 오를리스타트 및 대변 연화제를 포함하는 비만의 예방 또는치료용 조성물
ES2350798T3 (es) * 2007-09-12 2011-01-27 Mader S.R.L. Composiciones farmacéuticas para uso oral para tratar a pacientes afectados por la obesidad.
EP2044930A1 (en) * 2007-10-01 2009-04-08 Nestec S.A. Composition for controlling lipase catalyzed reactions
PL216542B1 (pl) 2008-03-20 2014-04-30 Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna Sposób wytwarzania stabilnej kompozycji orlistatu w postaci kapsułkowanego proszku
WO2010042499A1 (en) * 2008-10-06 2010-04-15 Banner Pharmacaps, Inc. Stable solutions of orlistat for pharmaceutical dosage forms
KR20100075260A (ko) * 2008-12-24 2010-07-02 주식회사종근당 리파아제 저해제의 부작용 개선을 위한 신규한 약제학적 조성물
BRPI0901602B8 (pt) 2009-04-03 2021-05-25 Ems S/A formulação farmacêuticas
ITRM20120331A1 (it) 2012-07-12 2014-01-13 Guidotti & C Spa Labor Composizioni pediatriche orali liquide contenenti nepadutant.
BR112017021995A2 (pt) * 2015-04-14 2018-07-10 Zim Laboratories Ltd formulação farmacêutica compreendendo drogas de baixa fusão e altamente lipofílicas e método de melhora da dissolução
CN106310287B (zh) * 2015-06-25 2019-03-19 山东省药学科学院 新利司他药用组合物及其制备方法
MY196635A (en) * 2018-06-22 2023-04-25 Sime Darby Plantation Intellectual Property Sdn Bhd Method For Reducing Formation of Free Fatty Acids in Plants
CN115105476B (zh) * 2021-03-23 2023-11-14 山东新时代药业有限公司 一种奥利司他冻干口服制剂及其制备工艺
CN114983938A (zh) * 2022-05-19 2022-09-02 广东嘉博制药有限公司 一种奥利司他口服复合乳液及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1247547A (en) * 1983-06-22 1988-12-28 Paul Hadvary Leucine derivatives
EP0281200B1 (en) * 1987-03-02 1994-01-19 Yamanouchi Europe B.V. Pharmaceutical composition, pharmaceutical granulate and process for their preparation
CA2128044C (en) * 1993-08-05 2007-02-20 Klaus-Dieter Bremer Pharmaceutical compositions comprising a glucosidase and/or amylase inhibitor, and a lipase inhibitor
IT1282673B1 (it) 1996-02-23 1998-03-31 Ist Naz Stud Cura Dei Tumori Derivati della camptotecina e loro uso come agenti antitumorali
CA2264718C (en) 1996-09-01 2006-05-30 Pharmos Corporation Solid coprecipitates for enhanced bioavailability of lipophilic substances
US5891469A (en) * 1997-04-02 1999-04-06 Pharmos Corporation Solid Coprecipitates for enhanced bioavailability of lipophilic substances
US6004996A (en) * 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions
KR100479968B1 (ko) * 1997-02-05 2005-03-30 에프. 호프만-라 로슈 아게 위장 리파아제 억제제의 용도
US6267952B1 (en) 1998-01-09 2001-07-31 Geltex Pharmaceuticals, Inc. Lipase inhibiting polymers
AU759388B2 (en) 1998-08-14 2003-04-10 Cheplapharm Arzneimittel Gmbh Pharmaceutical compositions containing lipase inhibitors and chitosan
KR20010079635A (ko) 1998-08-14 2001-08-22 프리돌린 클라우스너, 롤란드 비. 보레르 리파아제 저해제를 함유하는 약학 조성물
US6368622B2 (en) * 1999-01-29 2002-04-09 Abbott Laboratories Process for preparing solid formulations of lipid regulating agents with enhanced dissolution and absorption

Also Published As

Publication number Publication date
DE60029602D1 (de) 2006-09-07
JO2386B1 (en) 2007-06-17
PL199870B1 (pl) 2008-11-28
UY26338A1 (es) 2000-10-31
CZ301901B6 (cs) 2010-07-28
KR20020063852A (ko) 2002-08-05
JP2003509357A (ja) 2003-03-11
DE60029602T2 (de) 2007-07-26
MY130200A (en) 2007-06-29
ME00674B (me) 2011-12-20
NO331906B1 (no) 2012-04-30
CZ20021276A3 (cs) 2003-04-16
US20040175420A1 (en) 2004-09-09
KR100572434B1 (ko) 2006-04-18
TR200200606T2 (tr) 2002-07-22
PT1216025E (pt) 2006-12-29
SI1216025T1 (sl) 2006-12-31
BRPI0013939B1 (pt) 2017-07-18
HUP0202737A2 (hu) 2003-01-28
MA26818A1 (fr) 2004-12-20
ZA200201518B (en) 2003-07-30
BR0013939A (pt) 2002-05-14
IL148494A0 (en) 2002-09-12
CA2383916C (en) 2009-01-20
CA2383916A1 (en) 2001-03-22
HRP20020205B1 (en) 2011-06-30
PL356174A1 (en) 2004-06-14
HUP0202737A3 (en) 2005-01-28
AU7286300A (en) 2001-04-17
CN1197551C (zh) 2005-04-20
PE20010595A1 (es) 2001-05-26
EP1216025B1 (en) 2006-07-26
US8012494B2 (en) 2011-09-06
NZ517545A (en) 2003-11-28
JP4217016B2 (ja) 2009-01-28
ATE333866T1 (de) 2006-08-15
YU17202A (sh) 2006-01-16
MEP90808A (en) 2011-12-20
CO5180587A1 (es) 2002-07-30
ES2267563T3 (es) 2007-03-16
TWI243060B (en) 2005-11-11
WO2001019340A1 (en) 2001-03-22
HU228858B1 (en) 2013-06-28
DK1216025T3 (da) 2006-10-30
AR025587A1 (es) 2002-12-04
US20110275706A1 (en) 2011-11-10
RU2239428C2 (ru) 2004-11-10
NO20021204D0 (no) 2002-03-12
HRP20020205A2 (en) 2004-04-30
EP1216025A1 (en) 2002-06-26
EG24117A (en) 2008-07-06
HK1049966A1 (en) 2003-06-06
NO20021204L (no) 2002-03-12
RS50422B (sr) 2009-12-31
CN1373656A (zh) 2002-10-09
MXPA02002034A (es) 2002-08-20
US20030181512A1 (en) 2003-09-25
AU769415B2 (en) 2004-01-29

Similar Documents

Publication Publication Date Title
CY1106180T1 (el) Σκευασματα διασπορας τα οποια πepιεχουν αναστολεις λιπασης
BG104780A (en) Inhibitors of phospholipase enzymes
TR200103216T2 (tr) Pirimidinon bileşimleri
CY1105538T1 (el) Ιατρικη μορφοποιηση αερολυματος
DK0960107T3 (da) 6-Thiosubstituerede paclitaxeler
CR6883A (es) Composiciones farmaceuticas de inhibidores de la potencia de colesteril ester
CY1105009T1 (el) Συνθεση καχαλαλιδης f
ES2151277T3 (es) Composiciones que comprenden conjugados de acido cis-docosahexaenoico y taxotere.
DK0639577T3 (da) Phosphonooxymethyl- eller methylthiomethylestere af taxanderivater som antitumormidler
DE60232653D1 (de) Pharmazeutisch wirksame uridinester
TR199800773T2 (xx) Trombin inhibit�rleri.
DE60019100D1 (de) Im wesentlichen ölfreie cyclosporin zusammensetzungen
TR200001554T2 (tr) Yeni bileşimler.
TR200101756T2 (tr) Protein kinaz inhibitörleri olarak 4,5-pirazinoksindoller.
PT1282418E (pt) Utilizacao de derivados pirazolo para o tratamento da infertilidade
ATE242630T1 (de) Beladene bakterienghosts als träger- und targetingvehikel
DE60025392D1 (de) Behälter für feuchtigkeitstücher
BR0113634A (pt) Antibióticos de cefalosporina e suas pró-drogas
ATE315380T1 (de) Epothilon zusammensetzungen
HUP0300730A2 (hu) Eljárás instabil angina pectoris kezelésére
DK0977871T3 (da) Neurotrypsin
ATE315629T1 (de) Bleichmittelzusammensetzungen
DK1011329T3 (da) 7-Methylthiooxomethyl- og 7-methylthiodioxomethyl-paclitaxeler
FR2783518B1 (fr) Inhibiteurs de lta4 hydrolase
ECSP003654A (es) Formulaciones de dispersion que contienen inhibidores de lipasa